Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic peripheral blood stem cell transplantation significantly increases risk of chronic graft-versus-host disease of lung compared with bone marrow transplantation.
Alam N, Marras TK, Atenafu EG, Gupta V, Kuruvilla J, Lipton JH, Messner HA, Kim DD. Alam N, et al. Among authors: kim dd. Biol Blood Marrow Transplant. 2012 Dec;18(12):1905-10. doi: 10.1016/j.bbmt.2012.07.012. Epub 2012 Jul 23. Biol Blood Marrow Transplant. 2012. PMID: 22835425 Free article.
A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantation.
Shanavas M, Messner HA, Kamel-Reid S, Atenafu EG, Gupta V, Kuruvilla J, Kim DD, Uhm J, Lambie A, Ellis L, Lipton JH. Shanavas M, et al. Among authors: kim dd. Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):87-92. doi: 10.1016/j.clml.2013.09.010. Epub 2013 Oct 1. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24252361
Molecular relapse after allogeneic hematopoietic cell transplant for chronic myeloid leukemia: some long-term survivors appear to tolerate even lack of major molecular response.
Shanavas M, Messner HA, Kamel-Reid S, Atenafu EG, Gupta V, Kuruvilla J, Kim DD, Uhm J, Lambie A, Ellis L, Lipton JH. Shanavas M, et al. Among authors: kim dd. Leuk Lymphoma. 2014 Oct;55(10):2398-401. doi: 10.3109/10428194.2014.882507. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24428200 No abstract available.
Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Uhm J, Hamad N, Shin EM, Michelis FV, Shanavas M, Gupta V, Kuruvilla J, Lipton JH, Messner HA, Seftel M, Kim DD. Uhm J, et al. Among authors: kim dd. Biol Blood Marrow Transplant. 2014 Nov;20(11):1751-7. doi: 10.1016/j.bbmt.2014.07.001. Epub 2014 Jul 17. Biol Blood Marrow Transplant. 2014. PMID: 25042736 Free article.
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI Score.
Michelis FV, Messner HA, Uhm J, Alam N, Lambie A, McGillis L, Seftel MD, Gupta V, Kuruvilla J, Lipton JH, Kim DD. Michelis FV, et al. Among authors: kim dd. Clin Lymphoma Myeloma Leuk. 2015 May;15(5):e73-81. doi: 10.1016/j.clml.2014.09.014. Epub 2014 Oct 5. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25458081
5,109 results